Slovakia faces health challenges including drug shortages impacting epilepsy patients, a rise in colorectal cancer among young people, and unique maternity care options. Plus, a diabetes drug shows promise in treating alcoholism. Read more...

A summary of Q4 2024 earnings call transcripts from various companies including Oxford Nanopore, NeuroPace, Stem, OrthoPediatrics, Ingram Micro, and Cryoport, highlighting key insights. Read more...

Praxis faces a complex investment landscape. Despite a "Hold" rating and setbacks with Ulixacaltamide, the company presents a high-risk, high-reward opportunity in the epilepsy sector. Read more...

This week in health news: the UK government tackles dental hygiene, a warning about gas cooker pollution, and a welcome shift in UK doctor demographics towards greater diversity. Read more...